ModAstera

ModAstera Inc. , d. b. a.

ModAstera, is an innovative technology firm focused on enhancing artificial intelligence solutions specifically for the healthcare sector, streamlining operations for health tech companies to improve efficiency and patient outcomes. ModAstera Inc. , d. b.

a. ModAstera, was founded in 2025 and operates a platform that specializes in artificial intelligence development for healthcare applications. The company is based in Tokyo, Japan, and has completed 1 deal to date. It raised JPY 28 million in funding on February 11, 2025, from Antler, marking the total amount raised at JPY 28 million.

The founder has a background in technology entrepreneurship, although specific prior ventures are not detailed. ModAstera specializes in a comprehensive platform designed to enhance the development of artificial intelligence solutions specifically within the healthcare sector. Their core offerings include an AI Engineering Agent that accelerates the AI development workflow by automating tasks related to data preprocessing, annotation, model building, and deployment. This platform addresses critical use cases such as medical imaging, diagnostics, and patient monitoring, targeting health tech companies aiming to streamline their operations and reduce development costs.

By leveraging AI to pre-label medical data, users can efficiently create segmentation and classification models, thereby cutting down on time and manual effort. ModAstera’s services cater to a diverse client base, including healthcare providers, research institutions, and technology developers across North America, Europe, and Asia, focusing on improving patient outcomes and facilitating innovations in medical technology. ModAstera generates revenue through a subscription-based model, allowing clients to access their platform and associated tools for AI development. The transaction structure typically involves health tech companies entering agreements for varying levels of service, which may include access to pre-built healthcare-specific AI models and customizable annotation workflows.

Clients benefit from a pricing structure that reflects the range of services utilized, including support for both novice and advanced users depending on their specific needs. The platform's built-in compliance with healthcare regulations ensures that clients can efficiently manage sensitive data while integrating AI solutions into their workflows. ModAstera’s focus on delivering tailored services and tools enables them to build long-term partnerships within the health tech ecosystem, promoting sustained revenue through enhanced client engagement. ModAstera is currently designing new products aimed at expanding its service offerings in the healthcare AI sector, with plans for release in late 2025.

The company aims to broaden its market presence by entering the European and North American markets by mid-2026. The recent funding of JPY 28 million will support these initiatives, providing resources for product development and market expansion efforts.